Zapenia 100 mg is an atypical antipsychotic medication used for the management of schizophrenia in patients who are unresponsive or intolerant to conventional antipsychotics and for psychosis associated with Parkinson’s disease. It belongs to the dibenzodiazepine class and works by modulating dopamine and serotonin receptors in the brain, providing effective control of psychotic symptoms with a lower risk of extrapyramidal side effects.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Atypical Neuroleptic Drug
Zapenia 100 mg is indicated for:
Schizophrenia in adults unresponsive or intolerant to traditional antipsychotics
Psychosis in patients with Parkinson’s disease
It is especially useful in cases where conventional antipsychotics are ineffective or cause severe side effects.
Zapenia 100 mg acts primarily through antagonism of D2 and 5-HT2A receptors. It also has antagonistic effects on α-adrenergic, histamine H1, cholinergic, and other dopaminergic and serotonergic receptors. Its preferential activity at limbic over striatal dopamine receptors reduces the risk of extrapyramidal symptoms, while providing antipsychotic efficacy.
Schizophrenia (Adults over 16 years):
Day 1: 12.5 mg once or twice
Day 2: 25 mg once or twice
Gradually increase by 25–50 mg/day over 14–21 days up to 300 mg/day
Usual maintenance dose: 200–450 mg/day in divided doses; maximum 900 mg/day
Elderly (≥60 years):
Start with 12.5 mg once on day 1, increasing by 25 mg increments
Psychosis in Parkinson’s Disease:
Start 12.5 mg at bedtime, increase by 12.5 mg up to twice weekly
Usual dose: 25–37.5 mg/day
Maximum: 100 mg/day
Doses should be adjusted based on response and tolerability. Abrupt discontinuation should be avoided; gradual tapering over 1–2 weeks is recommended.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
May interact with CNS-active drugs, alcohol, or myelosuppressive agents
Can potentiate hypotensive effects with other antihypertensives
May displace or be displaced by highly protein-bound drugs (e.g., warfarin, digoxin)
Caution with CYP2D6 inhibitors or drugs metabolized by CYP2D6
Avoid concomitant adrenaline use due to α-adrenergic blockade
Severe cardiac disorders (myocarditis, cardiomyopathy)
Bone marrow disorders, neutropenia, or agranulocytosis
Paralytic ileus, alcoholic or toxic psychoses
Severe CNS depression or uncontrolled epilepsy
Breastfeeding mothers
Common:
Drowsiness, dizziness, headache
Constipation, nausea, vomiting
Increased salivation, mild weight gain
Less common:
Abdominal discomfort, dry mouth
Orthostatic hypotension, tachycardia
Serious but rare:
Agranulocytosis, myocarditis, cardiomyopathy
Thromboembolism, neuroleptic malignant syndrome
Monitor WBC weekly for the first 6 months; every other week if stable
Use caution in elderly patients and those with seizure risk, diabetes, or hepatic impairment
Monitor for signs of myocarditis or cardiomyopathy
Avoid sudden discontinuation
Overdose may cause drowsiness, delirium, hypotension, tachycardia, respiratory depression, seizures, or coma. Management includes airway support, activated charcoal, monitoring of cardiac and vital signs, and symptomatic treatment.
Pregnancy Category B: Use only if clearly necessary
Not recommended during breastfeeding; may be excreted in milk
Store below 30°C in a dry place, protected from light. Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet